Cargando…
Questionnaire-based Pan-India survey for impact assessment of National Formulary of India
OBJECTIVES: The National Formulary of India (NFI), a ready reckoner for medicines among healthcare-professionals aims for promoting rational drug use. This needs periodic update based on evidence-based medicines and suggestions from end-users. This study assessed the level of awareness among health-...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265414/ https://www.ncbi.nlm.nih.gov/pubmed/34100395 http://dx.doi.org/10.4103/ijp.ijp_353_21 |
_version_ | 1783719759796240384 |
---|---|
author | Sarangi, Sudhir Chandra Medhi, Bikash Prakash, Ajay Prakash, Jai Gupta, Yogendra K. |
author_facet | Sarangi, Sudhir Chandra Medhi, Bikash Prakash, Ajay Prakash, Jai Gupta, Yogendra K. |
author_sort | Sarangi, Sudhir Chandra |
collection | PubMed |
description | OBJECTIVES: The National Formulary of India (NFI), a ready reckoner for medicines among healthcare-professionals aims for promoting rational drug use. This needs periodic update based on evidence-based medicines and suggestions from end-users. This study assessed the level of awareness among health-care professionals and sought suggestions for enhancement of utility/content of NFI. MATERIALS AND METHODS: This pan-India cross-sectional, questionnaire-based survey was conducted between November-2020 and March-2021. A Google-doc-based validated questionnaire (20 questions) was circulated through E-mail/social media groups and to 311 medical institutes/hospitals/clinics across India through the adverse drug reaction monitoring centers under the Pharmacovigilance Program of India. RESULTS: A total of 461 participants (39-interns, 167-resident doctors, and the rest practicing physicians/doctors) affiliated to 224 institutes/hospitals/clinics had responded. About 46% respondents consulted NFI for drug-related information and 82.3% stated that NFI provides balanced unbiased information. About 95% respondents were aware of NFI's content and 76% mentioned usefulness of NFI in their clinical practice; however, 34.4% had misconceptions about NFI, 28.7% had a false belief that NFI is a legal document to safeguard health-care providers and 22.2% had never used it. Suggestions to enhance NFI's utility included digital accessibility, incorporation of information like drugs for basic medical emergencies (71.3%), disposal of expired-pharmaceutical products (38.7%), pharmaceutical price control policy (36.3%), and drug-procurement practices in hospitals (35.6%). CONCLUSION: As per the survey findings, NFI is an effective tool for instant access to precise and unbiased drug-related information, and fostering rational use of drugs. Boosting its practical usefulness needs incorporation of suggested information, digital accessibility, and periodic update. |
format | Online Article Text |
id | pubmed-8265414 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-82654142021-07-16 Questionnaire-based Pan-India survey for impact assessment of National Formulary of India Sarangi, Sudhir Chandra Medhi, Bikash Prakash, Ajay Prakash, Jai Gupta, Yogendra K. Indian J Pharmacol Research Article OBJECTIVES: The National Formulary of India (NFI), a ready reckoner for medicines among healthcare-professionals aims for promoting rational drug use. This needs periodic update based on evidence-based medicines and suggestions from end-users. This study assessed the level of awareness among health-care professionals and sought suggestions for enhancement of utility/content of NFI. MATERIALS AND METHODS: This pan-India cross-sectional, questionnaire-based survey was conducted between November-2020 and March-2021. A Google-doc-based validated questionnaire (20 questions) was circulated through E-mail/social media groups and to 311 medical institutes/hospitals/clinics across India through the adverse drug reaction monitoring centers under the Pharmacovigilance Program of India. RESULTS: A total of 461 participants (39-interns, 167-resident doctors, and the rest practicing physicians/doctors) affiliated to 224 institutes/hospitals/clinics had responded. About 46% respondents consulted NFI for drug-related information and 82.3% stated that NFI provides balanced unbiased information. About 95% respondents were aware of NFI's content and 76% mentioned usefulness of NFI in their clinical practice; however, 34.4% had misconceptions about NFI, 28.7% had a false belief that NFI is a legal document to safeguard health-care providers and 22.2% had never used it. Suggestions to enhance NFI's utility included digital accessibility, incorporation of information like drugs for basic medical emergencies (71.3%), disposal of expired-pharmaceutical products (38.7%), pharmaceutical price control policy (36.3%), and drug-procurement practices in hospitals (35.6%). CONCLUSION: As per the survey findings, NFI is an effective tool for instant access to precise and unbiased drug-related information, and fostering rational use of drugs. Boosting its practical usefulness needs incorporation of suggested information, digital accessibility, and periodic update. Wolters Kluwer - Medknow 2021 2021-05-26 /pmc/articles/PMC8265414/ /pubmed/34100395 http://dx.doi.org/10.4103/ijp.ijp_353_21 Text en Copyright: © 2021 Indian Journal of Pharmacology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Research Article Sarangi, Sudhir Chandra Medhi, Bikash Prakash, Ajay Prakash, Jai Gupta, Yogendra K. Questionnaire-based Pan-India survey for impact assessment of National Formulary of India |
title | Questionnaire-based Pan-India survey for impact assessment of National Formulary of India |
title_full | Questionnaire-based Pan-India survey for impact assessment of National Formulary of India |
title_fullStr | Questionnaire-based Pan-India survey for impact assessment of National Formulary of India |
title_full_unstemmed | Questionnaire-based Pan-India survey for impact assessment of National Formulary of India |
title_short | Questionnaire-based Pan-India survey for impact assessment of National Formulary of India |
title_sort | questionnaire-based pan-india survey for impact assessment of national formulary of india |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265414/ https://www.ncbi.nlm.nih.gov/pubmed/34100395 http://dx.doi.org/10.4103/ijp.ijp_353_21 |
work_keys_str_mv | AT sarangisudhirchandra questionnairebasedpanindiasurveyforimpactassessmentofnationalformularyofindia AT medhibikash questionnairebasedpanindiasurveyforimpactassessmentofnationalformularyofindia AT prakashajay questionnairebasedpanindiasurveyforimpactassessmentofnationalformularyofindia AT prakashjai questionnairebasedpanindiasurveyforimpactassessmentofnationalformularyofindia AT guptayogendrak questionnairebasedpanindiasurveyforimpactassessmentofnationalformularyofindia |